跳至主要内容
临床试验/NCT02197338
NCT02197338已完成不适用

Randomized Controlled Trial of Short Versus Long Wire and Small Versus Standard Sphincterotomes for Initial Biliary Cannulation

University of Southern California1 个研究点 分布在 1 个国家目标入组 498 人开始时间: 2016年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
498
试验地点
1
主要终点
Bile Duct Cannulation

研究概览

简要总结

  1. Cannulation of (placement of a small catheter into) the bile duct is critical to remove bile duct stones, divert bile leaks, and decompress biliary obstruction due to cancer.
  2. Given the small size of the bile duct orifice and its close proximity to the pancreatic duct, selective biliary cannulation is the most difficult part of the endoscopic retrograde cholangiography (ERCP).
  3. New small diameter sphincteromes and "short wire" systems (which allow physicians to control guidewires) offer potential, though untested advantages.
  4. At most hosptial both the long and short wire systems as well as small versus standard are routinely used for clinical care.
  5. Our hypothesis is that small diameter, physician controlled wires favor biliary cannulation
  6. Our objective will be to assess whether small diameter sphincterotomes and "short wire" physician controlled guidewire cannulation favors successful bile duct cannulation and minimize complications.

详细描述

1.0 BACKGROUND

Bile duct access is the most difficult part of endoscopic retrograde cholangiography (ERCP) performed for the biliary indications of bile duct stones, leak, and stricture. In the past decade there has been an evolution in the technology and approach used to achieve selective biliary cannulation, In the classic approach a standard cannula is placed into the biliary orifice and contrast injected to confirm placement. Subsequently, a long wire is passed by the assistant deeply into the duct and the cannulatome exchange for a sphincterotome which is used to perform papillotomy.

The first major change in cannulation approach has been the widespread use of the sphincterotome to obtain initial biliary access in lieu of the cannulatome. This is in part driven by economics. With the advent of endoscopic ultrasound (EUS) and magnetic resonance cholangiopancreatography (MRCP) almost all ERCP is therapeutic and sphincterotomy is typically part of this approach.1 Thus it is sensible to forgo the step of using the cannulatome which enables only diagnostic ERCP. In addition to cutting, the wire on the distal tip of the sphincterotome enables variable flexion in the direction of the bile duct, a feature lacking for the cannulatome.

Additionally, high quality comparison trials suggest that the sphincterotome is superior to the cannulatome for initial access. Schwacha et al prospectively randomized patients to bile duct cannulation with the standard cannulatome versus the sphincterotome.2 After five attempts bile duct access was achieved in 62% of those in the standard catheter group compared to 84% in the sphincterotome group. Cortus et al randomized patients to <15 attempts to access with bile duct with the cannulatome versus the sphincterotome and found that initial biliary access was obtained in 67% in the former versus 97% in the latter groups.3 In addition the mean number of cannulation attempts and time to achieve selective biliary cannulation was also less in the sphincterotome group. Given these considerations most American endoscopists use sphincterotomes for initial biliary cannulation.4

Most modern sphincterotomes have two to three lumens to enable simulatenous passage of contrast and wire into the bile duct. Traditionally, contrast was first injected to confirm that the bile duct as opposed to the pancreatic duct had been accessed. In 2004 Lella randomized 400 patients to the standard approach of contrast injection versus the passage of the guidewire to confirm bile duct cannulation.5 In the contrast group 4% of patients developed pancreatitis compared to none in the wire guided group and high pancreatic enzyme levels (5 times the upper limit of normal) developed in 20% of contrast guided versus 5% of wire guided cases. Subsequent large randomized trials have consistently demonstrated post ERCP pancreatitis rates of 2-9% in wire guided versus 10-17% in contrast guided ERCP.6-7 Wire guided cannulation has also been shown to shorten cannulation and fluoroscopy times.8

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Undergoing ERCP at LAC+USC Medical Centers for standard indications including bile duct stones, bile leak, and biliary obstruction will be included.

排除标准

  • •Prior ERCP with sphincterotomy
  • •Prior ERCP with failed bile duct cannulation
  • •Pregnant, imprisoned, under age 18, unable to give informed consent
  • •Prior biliary diversion surgery will be excluded
  • •Those who require ERCP only for pancreatic duct indications will also be excluded as bile duct cannulation is not clinically necessary in this group

研究组 & 干预措施

Short Wire, Small Tome

Experimental

Short wire system, small sized sphincterotome will be used to perform the Intervention of Bile Duct Cannulation.

干预措施: Bile Duct Cannulation (Other)

Short Wire, Standard Tome

Active Comparator

Short wire system, standard sized sphincterotome will be used to perform the Intervention of Bile Duct Cannulation.

干预措施: Bile Duct Cannulation (Other)

Long Wire, Small Tome

Active Comparator

Long wire system, small sized sphincterotome will be used to perform the Intervention of Bile Duct Cannulation.

干预措施: Bile Duct Cannulation (Other)

Long Wire, Standard Tome

Active Comparator

Long wire system, standard sized sphincterotome will be used to perform the Intervention of Bile Duct Cannulation.

干预措施: Bile Duct Cannulation (Other)

结局指标

主要结局

Bile Duct Cannulation

时间窗: 1 year

The primary outcome is successful initial cannulation as defined by bile duct with the assigned technology (ie size of cannulatome and type of wire system) within the first 8 attempts. The rates of cannulation among the 4 groups will be compared.

次要结局

  • Post ERCP Pancreatitis(1 year)
  • Number of Cannulation Attempts(1 Year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

James Buxbaum

Assistant Professor

University of Southern California

研究点 (1)

Loading locations...

相似试验